Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)
|
November 23, 2007
[Aspiration of ascites]
K Muehlenberg, K Wiedmann
Munchener Medizinische Wochenschrift (1950)
|
November 6, 1970
[Obstructive jaundice (experiences with 452 treated cases)]
M Bauer, K Flintsch, K Wiedmann
Behaviour Research and Therapy
|
January 1, 1990
The effects of muscle tension on cerebral circulation in blood-phobic and non-phobic subjects
J Foulds, K Wiedmann, J Patterson, et al.
Inorganic Chemistry
|
June 9, 2009
Volatility and high thermal stability in tantalum complexes containing imido, amidinate, and halide or dialkylamide ligands
Monika K Wiedmann, Mary Jane Heeg, Charles H Winter
Applied Optics
|
October 3, 2009
Optical properties of Al2O3 thin films grown by atomic layer deposition
Pradeep Kumar, Monika K Wiedmann, Charles H Winter, et al.
Zeitschrift Fur Gastroenterologie
|
January 12, 2008
[Recurrent intrahepatic cholestasis of pregnancy and chain-like choledocholithiasis in a female patient with stop codon in the ABDC4-gene of the hepatobiliary phospholipid transporter]
K Muehlenberg, K Wiedmann, H Keppeler, et al.
Der Unfallchirurg
|
June 1, 2011
[Clinical evaluation of PFNA® and relationship between the tip-apex distance and mechanical failure]
M Kraus, G Krischak, K Wiedmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 1988
Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients
R A Gillham, N Williams, K Wiedmann, et al.
Journal of the American Chemical Society
|
September 27, 2007
A pyrazolate-based metalorganic tantalum precursor that exhibits high thermal stability and its use in the atomic layer deposition of ta(2)o(5)
Charles L Dezelah, Monika K Wiedmann, Kenichiro Mizohata, et al.
Medical Oncology (Northwood, London, England)
|
November 4, 2017
Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial
I Walter, U Schulz, M Vogelhuber, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Deutsche Medizinische Wochenschrift (1946)
|
November 23, 2007
[Aspiration of ascites]
K Muehlenberg, K Wiedmann
Munchener Medizinische Wochenschrift (1950)
|
November 6, 1970
[Obstructive jaundice (experiences with 452 treated cases)]
M Bauer, K Flintsch, K Wiedmann
Behaviour Research and Therapy
|
January 1, 1990
The effects of muscle tension on cerebral circulation in blood-phobic and non-phobic subjects
J Foulds, K Wiedmann, J Patterson, et al.
Inorganic Chemistry
|
June 9, 2009
Volatility and high thermal stability in tantalum complexes containing imido, amidinate, and halide or dialkylamide ligands
Monika K Wiedmann, Mary Jane Heeg, Charles H Winter
Applied Optics
|
October 3, 2009
Optical properties of Al2O3 thin films grown by atomic layer deposition
Pradeep Kumar, Monika K Wiedmann, Charles H Winter, et al.
Zeitschrift Fur Gastroenterologie
|
January 12, 2008
[Recurrent intrahepatic cholestasis of pregnancy and chain-like choledocholithiasis in a female patient with stop codon in the ABDC4-gene of the hepatobiliary phospholipid transporter]
K Muehlenberg, K Wiedmann, H Keppeler, et al.
Der Unfallchirurg
|
June 1, 2011
[Clinical evaluation of PFNA® and relationship between the tip-apex distance and mechanical failure]
M Kraus, G Krischak, K Wiedmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 1988
Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients
R A Gillham, N Williams, K Wiedmann, et al.
Journal of the American Chemical Society
|
September 27, 2007
A pyrazolate-based metalorganic tantalum precursor that exhibits high thermal stability and its use in the atomic layer deposition of ta(2)o(5)
Charles L Dezelah, Monika K Wiedmann, Kenichiro Mizohata, et al.
Medical Oncology (Northwood, London, England)
|
November 4, 2017
Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial
I Walter, U Schulz, M Vogelhuber, et al.
Page
of 2